Laurus Labs share news, announcements and annual reports
NSE: LAURUSLABSBSE: 540222Pharmaceuticals & BiotechnologyMid Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹2,405.50.
2 Nov: open ₹2,406.00, high ₹2,441.90, low ₹2,347.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,26,865 Cr171st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 94.68
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 20.93
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.05%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 24.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 21.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 30,47,24950.1% delivered
Laurus Labs board meetings
58 filed, newest first. Page 1 of 2.
Oct 2026
Jul 2026
9 Jul · Board meeting
Apr 2026
Jan 2026
9 Jan · Board meeting
Oct 2025
Jul 2025
9 Jul · Board meeting
May 2025
Apr 2025
Jan 2025
6 Jan · Board meeting
Oct 2024
Jul 2024
25 Jul · Board meeting
19 Jul · Board meeting
Apr 2024
Jan 2024
17 Jan · Board meeting
Oct 2023
20 Oct · Board meeting
Sep 2023
11 Sep · Board meeting
Jul 2023
20 Jul · Board meeting
Apr 2023
Jan 2023
30 Jan · Board meeting
21 Jan · Board meeting
Oct 2022
Jul 2022
Apr 2022
Jan 2022
19 Jan · Board meeting
Oct 2021
28 Oct · Board meeting
Jul 2021
19 Jul · Board meeting
Apr 2021
29 Apr · Board meeting
Jan 2021
28 Jan · Board meeting
Oct 2020
29 Oct · Board meeting
Jul 2020
21 Jul · Board meeting
Apr 2020
30 Apr · Board meeting
Mar 2020
12 Mar · Board meeting
Jan 2020
20 Jan · Board meeting
Oct 2019
21 Oct · Board meeting
Jul 2019
24 Jul · Board meeting
Apr 2019
25 Apr · Board meeting
Jan 2019
Oct 2018
23 Oct · Board meeting
Aug 2018
3 Aug · Board meeting
Jul 2018
May 2018
10 May · Board meeting